Benign Lymphoproliferative Disorder: Clinical Trials

2 trials for Benign Lymphoproliferative Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. .

Follow Benign Lymphoproliferative Disorder: new trials by email Literature Review of Benign Lymphoproliferative Disorder trials Research Report on Benign Lymphoproliferative Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies
Primary Immune Deficiencies, Benign Lymphoproliferative Disorder
Not yet recruitingCentral Hospital, Nancy, France602026-04-012026-04-13
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Benign Lymphoproliferative Disorder
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)12001993-05-132026-11-12

Narrower conditions

Autoimmune Diseases (1)  ·  Autoimmune Lymphoproliferative Syndrome, Type IA (1)  ·  Lymphadenopathy (1)  ·  Primary Immunodeficiency Diseases (1)  ·  Splenomegaly (1)

Broader conditions

Immune System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypertrophy (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Lymphatic Diseases (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Central Hospital, Nancy, France (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (1)

Top investigators

V. Koneti Rao, M.D. (1)

Results publications

PMID 21885601, PMID 25359994, PMID 27846610